Market
RapidPulse obtains funding for stroke aspiration system
RapidPulse secured $48 million in funding to advance clinical development of its aspiration technology for acute ischemic stroke treatment. The capital will support the company's efforts to move the system through clinical validation and toward market commercialization.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network